Using large breast cancer datasets, researchers were able to show that, unsurprisingly, BRCA-1 and BRCA-2 mutated cancers did have an increased proportion of homologous recombination deficiency (HRD) genetic signatures and overall mutational load compared to BRCA proficient cancers [26]. This evidence concerns the gene BRCA1 and cancer.